Publication | Closed Access

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment

Lung Cancer TreatmentSystems BiologyOncogenic AgentMedicineProtein HyperactivationCancer GenomicsMet Gene AmplificationBronchial NeoplasmRadiation OncologyOncologyCell BiologyLung Cancer